Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries

Fig. 1

Comparison of PKU-QOL scores related to Phe-free amino acid supplements according to PKU severity (mild/moderate PKU: Phe level 600–1200 μmol/L; Classical PKU: Phe level >1200 μmol/L) in children (N = 92), adolescents (N = 110), parents (N = 253) and adults (N = 104). Box-plots presents the following: interquartile range (Q1-Q3); +: mean; –: median; bottom and top bars: observed minimum and maximum observed values; ○: outliers (i.e., values that are outside the distance of 1.5 times the interquartile range from Q1 or Q3)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172